Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies

O Saatci, KT Huynh-Dam, O Sahin - Journal of Molecular Medicine, 2021 - Springer
Abstract Estrogen receptor-positive (ER+) breast cancer accounts for approximately 75% of
all breast cancers. Endocrine therapies, including selective ER modulators (SERMs) …

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer

AJ Kiliti, GM Sharif, MB Martin, A Wellstein… - Frontiers in …, 2023 - frontiersin.org
The estrogen receptor alpha (ERα) is a steroid receptor that is pivotal in the initiation and
progression of most breast cancers. ERα regulates gene transcription through recruitment of …

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

N Cosgrove, D Varešlija, S Keelan, A Elangovan… - Nature …, 2022 - nature.com
The molecular events and transcriptional plasticity driving brain metastasis in clinically
relevant breast tumor subtypes has not been determined. Here we comprehensively dissect …

Novel pectin-like polysaccharide from Panax notoginseng attenuates renal tubular cells fibrogenesis induced by TGF-β

C Huang, X Jing, Q Wu, K Ding - Carbohydrate Polymers, 2022 - Elsevier
Renal fibrosis is the final common result of a variety of progressive injuries leading to
chronic renal failure. However, there are no effective clinical available drugs for the …

SRC-3, a steroid receptor coactivator: implication in cancer

L Li, CX Deng, Q Chen - International journal of molecular sciences, 2021 - mdpi.com
Steroid receptor coactivator-3 (SRC-3), also known as amplified in breast cancer 1 (AIB1), is
a member of the SRC family. SRC-3 regulates not only the transcriptional activity of nuclear …

The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation

H Zhang, M Gao, W Zhao, L Yu - Breast Cancer Research, 2023 - Springer
Background SND1 participates in tumorigenesis, tumour invasion and metastasis in different
cancers. Previous studies have shown that SND1 can promote the invasion and migration of …

Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target

L Varisli, GM Dancik, V Tolan, S Vlahopoulos - Cancers, 2023 - mdpi.com
Simple Summary Breast cancer is one of the most commonly diagnosed malignancies in
women and is also a leading cause of cancer related death. Estrogens play crucial roles in …

Epigenomic alterations in cancer: mechanisms and therapeutic potential

JS Gray, SA Wani, MJ Campbell - Clinical Science, 2022 - portlandpress.com
The human cell requires ways to specify its transcriptome without altering the essential
sequence of DNA; this is achieved through mechanisms which govern the epigenetic state …

The complex landscape of luminal breast cancer

C Lutz, HA Messal, D Vareslija… - Endocrine-Related …, 2025 - erc.bioscientifica.com
The breast epithelium, vital for mammary gland function, is influenced by oestrogen through
the oestrogen receptor (ER) signalling pathway. Luminal breast cancer (BC), characterised …

[HTML][HTML] Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer

J Zeng, L Zhang, S Ma, W Dai, M Xu, Y Wei… - Translational …, 2024 - Elsevier
Objectives Killer cell lectin like receptor G1 (KLRG1) is identified as a co-inhibitory receptor
for NK cells and antigen-experienced T cells. The role of KLRG1 in immune regulation in …